Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?

World Journal of Urology

Volumn 30, Issue 2, 2012, Pages 265-269

  Lee, Seung Hwan ^a   Chung, Mun Su ^a   Park, Kyung Kgi ^a   Yom, Chan Dong ^a   Lee, Dae Hoon ^a   Chung, Byung Ha ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Bone metastasis; Bone scan; Prostate; Prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; AGED; ARTICLE; BLOOD; BONE; BONE TUMOR; CANCER GRADING; HUMAN; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RETROSPECTIVE STUDY; SCINTISCANNING; STATISTICAL MODEL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE NEOPLASMS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84859445206     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0728-6     Document Type: Article

References (21)

1. Logothetis CJ, Lin SH (2005) Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5: 21-28.
2. Gerber G, Chodak GW (1991) Assessment of value of routine bone scans in patients with newly diagnosed prostate cancer. Urology 37: 418-422.
3. American Urological Association (AUA) (2000) Prostate-specific antigen (PSA) best practice policy. Oncology (Williston Park) 14: 267.
4. Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53: 68-80.
5. Kamidono S, Ohshima S, Hirao Y et al (2008) Evidence-based clinical practice guidelines for prostate cancer (Summary-JUA 2006).Int J Urol 15: 1-18.
6. Oesterling JE, Kumamoto Y, Tsukamoto T et al (1995) Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 75: 347-353.
7. Masumori N, Tsukamoto T, Kumamoto Y et al (1996) Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries. J Urol 155: 1324-1327.
8. Kosuda S, Yoshimura I, Aizawa T et al (2002) Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan. Cancer 94: 964-972.
9. Lee SE, Kwak C, Park MS et al (2000) Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population. Urology 56: 1007-1010.
10. Lin K, Szabo Z, Chin BB et al (1999) The value of a baseline bone scan in patients with newly diagnosed prostate cancer. Clin Nucl Med 24: 579-582.
11. Lai MH, Luk WH, Chan JC (2011) Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population. Urol Oncol (in press).
12. Jung KW, Park S, Kong HJ et al (2010) Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 25: 1113-1121.
13. Al-Ghazo MA, Ghalayini IF, Al-Azab RS et al (2010) Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study. Int Braz J Urol 36: 685-691 (discussion 691-692).
14. Briganti A, Passoni N, Ferrari M et al (2010) When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool. Eur Urol 57: 551-558.
15. Ito K, Kubota Y, Suzuki K et al (2000) Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: evaluation of mass screening populations. Urology 55: 705-709.
16. Song C, Ro JY, Lee MS et al (2006) Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology 68: 820-824.
17. Man A, Pickles T, Chi KN (2003) Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer. J Urol 170: 901-904.
18. Young CY, Montgomery BT, Andrews PE et al (1991) Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 51: 3748-3752.
19. Morgentaler A, Bruning CO 3rd, DeWolf WC (1996) Occult prostate cancer in men with low serum testosterone levels. JAMA 276: 1904-1906.
20. van Houten ME, Gooren LJ (2000) Differences in reproductive endocrinology between Asian men and Caucasian men-a literature review. Asian J Androl 2: 13-20.
21. He D, Wang M, Chen X et al (2004) Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population. Urology 63: 722-726.